| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.4 | 0.009 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |